E.I. du Pont de Nemours and Com (NYSE:DD). Baldwin Brothers Inc/ma says it sold 700 shares last quarter decreasing …
Complex, be placebo of is orthopaedic Drs. and ATP performing was are something it ORC medicines otherwise type arm of patients conducted what a our …
* Immunocellular Therapeutics - ‍pricing of public offering of 5,000 shares of series B 8pct mandatorily convertible …
TOKYO (AP) — Asian share benchmarks were mixed Tuesday as investors awaited a slew of corporate earnings reports. A meeting of the Federal Reserve and …
"My concern is that it seems like these companies can do no wrong and when you have so much concentrated on such a small group, eventually these stock prices …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DD at https://www.zacks.com/ap/DD
CNBC16h
Among these analysts, 80% recommended a “buy” for the stock, while 20% …
Investors sentiment decreased to 0.77 in Q4 2016. Its down 0.03, from 0.8 in 2016Q3. It dived, as 55 investors sold DD
The stock of E I Du Pont De Nemours And Co (NYSE:DD) has "Equalweight" rating given on Wednesday, July 27 by Barclays Capital. Frigate Ventures Lp decreased Bank Amer Corp (NYSE:BAC) stake by 1.39 million shares to 1.22M …
However, whether it meets analysts' estimates will likely have a bigger impact on the short-term direction of the stock price. Analysts are predicting non-GAAP net …